GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 82 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,100 | -37.7% | 21,570 | -29.4% | 0.00% | 0.0% |
| Q2 2023 | $59,567 | -29.9% | 30,547 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $84,921 | -19.4% | 30,547 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $105,387 | -85.0% | 30,547 | -44.2% | 0.00% | -88.9% |
| Q4 2021 | $703,000 | +48.6% | 54,700 | +24.9% | 0.02% | +100.0% |
| Q3 2021 | $473,000 | -19.3% | 43,800 | -31.7% | 0.01% | -18.2% |
| Q2 2021 | $586,000 | -7.1% | 64,167 | -4.1% | 0.01% | 0.0% |
| Q1 2021 | $631,000 | +140.8% | 66,927 | +0.7% | 0.01% | +120.0% |
| Q4 2020 | $262,000 | +33.7% | 66,467 | -10.2% | 0.01% | -16.7% |
| Q3 2020 | $196,000 | +51.9% | 74,056 | +282.5% | 0.01% | 0.0% |
| Q2 2020 | $129,000 | – | 19,363 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $17,536,000 | 1.82% |
| EcoR1 Capital, LLC | 3,421,287 | $13,480,000 | 0.72% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $8,123,000 | 0.63% |
| BVF INC/IL | 2,695,418 | $10,620,000 | 0.42% |
| Column Group LLC | 869,493 | $3,426,000 | 0.31% |
| Avidity Partners Management LP | 2,122,064 | $8,361,000 | 0.27% |
| Redmile Group, LLC | 3,059,794 | $12,056,000 | 0.15% |
| SkyOak Wealth, LLC | 69,778 | $275,000 | 0.09% |
| Tekla Capital Management LLC | 419,005 | $1,651,000 | 0.06% |
| Blackstone Inc. | 2,567,445 | $10,116,000 | 0.04% |